High-grade serous ovarian carcinoma presents significant clinical and therapeutic challenges. Although the traditional model of carcinogenesis has focused on the ovary as a tumor initiation site,… (More)
Proceedings of the National Academy of Sciences…
2012
Chemoresistance to platinum therapy is a major obstacle that needs to be overcome in the treatment of ovarian cancer patients. The high rates and patterns of therapeutic failure seen in patients are… (More)
The centrality of phosphoinositide-3-kinase (PI3K) in cancer etiology is well established, but clinical translation of PI3K inhibitors has been limited by feedback signaling, suboptimal intratumoral… (More)
Long-term survival of ovarian cancer patients is poor due to lack of early detection and high rates of therapeutic failure and chemoresistance. It is estimated that 15,500 women in the United States… (More)